Paul Tudor Jones’s T2 Biosystems, Inc TTOO Stock Holding History

Paul Tudor Jones’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,909	Closed	-$42.2K	–	3010
2023 Q3	$42.2K	Buy	+1,909	New	+$49.8K	﹤0.01%	2188

Other funds holding TTOO

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Paul Tudor Jones's TTOO Position: Q4 2023 in Review

Paul Tudor Jones sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 1,909 shares — an estimated $42.2K sold.

Paul Tudor Jones first reported a position in TTOO in Q3 2023 and held it in 1 quarter. The position peaked at $42.2K in Q3 2023. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

Paul Tudor Jones reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
Paul Tudor Jones sold 1,909 T2 Biosystems, Inc shares in Q4 2023, an estimated $42.2K.
Paul Tudor Jones first reported a position in T2 Biosystems, Inc in Q3 2023 and held it in 1 quarter.
Paul Tudor Jones's T2 Biosystems, Inc position peaked at $42.2K in Q3 2023.
21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.